<乌鸦传媒>Aging Mechanisms Tied to Giant Cell Arteritis Small study may help explain how some GCA drugs actually work Apr 17, 2023
<乌鸦传媒>The Drug Company That Prospered Without Creating Any Drugs A look at Horizon Therapeutics' tactics Apr 16, 2023
<乌鸦传媒>Interferon Blocker Crushes Macrophage Activation Syndrome Small trial shows promise for treating life-threatening complication of rheumatic diseases Apr 03, 2023
<乌鸦传媒>Asthma, Eczema Tied to Osteoarthritis Risk Suggests OA is not just about wear and tear Mar 29, 2023
<乌鸦传媒>RA in Remission? Stopping DMARDs May Be OK Provocative new data from ARCTIC REWIND Mar 28, 2023
<乌鸦传媒>Revolving Door in OR Makes Surgeries Less Efficient Intraoperative staff swaps tied to longer operative time for hip, knee replacements Mar 22, 2023
<乌鸦传媒>Tofacitinib May Reduce Risk of Interstitial Lung Disease in RA Patients Retrospective study shows a 69% lower risk with tofacitinib compared with adalimumab Mar 21, 2023
<乌鸦传媒>Docs' Liking for Knee Injection Tied to Industry Payments Threefold rate for giving hyaluronic acid shots among those paid more than $100 Mar 20, 2023
<乌鸦传媒>JAK Inhibitor Succeeds in Refractory Vasculitis Seven of 11 patients respond after failing multiple previous meds Mar 16, 2023
<乌鸦传媒>New Lupus Drug Cuts Skin Disease When Other Agents Fail Small study backs anifrolumab for salvage therapy Mar 15, 2023
<乌鸦传媒>Psoriatic Arthritis: Depressing News on Second- and Later-Line Treatments Real-world data indicate most patients who fail a first biologic drug never obtain remission Feb 27, 2023
<乌鸦传媒>Study Suggests Path Connecting Periodontal Disease With Rheumatoid Arthritis Exposing immune system to citrullinated bacterial proteins seen as trigger Feb 22, 2023
<乌鸦传媒>Taltz Safety, Efficacy Stay Robust in Spondyloarthritis at 3 Years Benefits appear durable for patients in a long-term extension Feb 21, 2023
<乌鸦传媒>Older Lupus Patients Need Follow-Up After Hospital Discharge ... or Else Medicare data show what happens when it's neglected Feb 09, 2023
<乌鸦传媒>Wearable Sensors Show Promise for Remote OA Assessment Provide good data and most patients can manage them, small trial indicates Feb 06, 2023
<乌鸦传媒>Rheumatoid Factor and ACPA, Meet Potential New Partners for RA Diagnosis Additional autoantibodies found to improve sensitivity in early-stage disease Feb 02, 2023
<乌鸦传媒>Study: Diminished COVID Vaccine Response in Lupus Immunosuppressants seem responsible; mycophenolate "holiday" may help Jan 30, 2023
<乌鸦传媒>Blood Test Bests Standard OA Prognostic Models in Early Study Multi-marker panel does a better job of predicting who will show rapid progression Jan 25, 2023
<乌鸦传媒>Inflammatory VEXAS Syndrome May Not Be So Uncommon Is new disease being missed by physicians? Jan 24, 2023
<乌鸦传媒>In Knee OA, Exercise Is Helpful ... But Maybe More in Mind Than Body Trial shows little extra benefit from intensive program Jan 23, 2023
<乌鸦传媒>IBD and Rheumatic Diseases Overlap Specialists in both fields need to communicate and coordinate, says researcher Jan 23, 2023
<乌鸦传媒>Novel Gout Drug Passes Mid-Stage Test Developers hope to improve on allopurinol, febuxostat Jan 20, 2023
<乌鸦传媒>IL-13 Blocker Beats Atopic Dermatitis With favorable results from three trials, approval seems likely Jan 11, 2023
<乌鸦传媒>JAK Inhibitor Promising for Polymyalgia Rheumatica Oral drug seen as safer than chronic, high-dose steroids Jan 09, 2023
<乌鸦传媒>New Guideline: Vaccinations OK With Few Tweaks for Rheum Patients No reason to withhold in vast majority of cases, ACR panel says Jan 05, 2023
<乌鸦传媒>Why Doesn't Exercise Help Everyone With Knee OA? Actually, the better question is why can't everyone do the recommended exercises Jan 04, 2023
<乌鸦传媒>Ashton Kutcher's Autoimmune Vasculitis The award-winning actor feels lucky to be alive after his health scare Jan 03, 2023
<乌鸦传媒>Data on Dupixent in Eosinophilic Esophagitis Now Published First peer-reviewed accounting of efficacy and safety results in pivotal trial Dec 21, 2022
<乌鸦传媒>Early OA Common in Military Officers After Knee Injury Many show joint degradation before age 30 Dec 20, 2022
<乌鸦传媒>It's a TNF Inhibitor! It's a Steroid! It's Two (Potential) RA Drugs in One! Hints in mid-stage trial that novel conjugate will surpass adalimumab in efficacy Dec 14, 2022
<乌鸦传媒>Xeljanz Cancer Risks Detailed New paper provides full results from ORAL Surveillance trial Dec 07, 2022
<乌鸦传媒>Not Just a Miner's Problem: Workplace Fumes, Dust Tied to RA Swedish study expands range of airborne toxics associated with rheumatic disease Dec 06, 2022
<乌鸦传媒>Cardiovascular Risk Marker Improved With Common Rheumatoid Arthritis Drugs Benefit seen with conventional DMARDs as well as biologics Dec 02, 2022
<乌鸦传媒>Study: New Moms Need Not Worry About Enbrel in Breast Milk Present in small amounts, but infants apparently unaffected in small sample Nov 28, 2022
<乌鸦传媒>Bone Drug Reverses Damage in Hand Osteoarthritis Provocative findings with denosumab, but don't reach for the prescription pad just yet Nov 15, 2022
<乌鸦传媒>Two Surgery Types Yield Similar Results in Advanced Ankle Osteoarthritis Similar clinical scores with either total ankle replacement or fusion surgery, trial shows Nov 14, 2022
<乌鸦传媒>Checkpoint Stimulator Passes Mid-Stage Test in Rheumatoid Arthritis Novel approach to normalizing immune activity Nov 14, 2022
<乌鸦传媒>For Better COVID Vax Response in Rheumatology Patients, Hold the MMF Longer Small study suggests at least a 10-day holiday Nov 14, 2022
<乌鸦传媒>Another Adalimumab Biosimilar Seems Set for Interchangeability Trial data pave way for FDA approval Nov 14, 2022
